BioSyent Inc. (RX.V)
CAD 11.2
(0.0%)
CAD 11.2
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.14 Million CAD | 10.0% |
| 2022 | 22.85 Million CAD | 0.97% |
| 2021 | 22.63 Million CAD | 29.92% |
| 2020 | 17.42 Million CAD | 4.67% |
| 2019 | 16.64 Million CAD | 0.43% |
| 2018 | 16.57 Million CAD | 3.75% |
| 2017 | 15.97 Million CAD | 13.08% |
| 2016 | 14.12 Million CAD | 16.65% |
| 2015 | 12.1 Million CAD | 27.06% |
| 2014 | 9.53 Million CAD | 54.84% |
| 2013 | 6.15 Million CAD | 54.5% |
| 2012 | 3.98 Million CAD | 80.5% |
| 2011 | 2.2 Million CAD | 78.53% |
| 2010 | 1.23 Million CAD | 86.35% |
| 2009 | 663.44 Thousand CAD | 2.44% |
| 2008 | 647.66 Thousand CAD | -14.97% |
| 2007 | 761.64 Thousand CAD | -25.79% |
| 2006 | 1.02 Million CAD | 165.81% |
| 2005 | 386.11 Thousand CAD | -12.16% |
| 2004 | 439.56 Thousand CAD | -1.88% |
| 2003 | 447.98 Thousand CAD | 22.73% |
| 2002 | 365.02 Thousand CAD | -9.89% |
| 2001 | 405.09 Thousand CAD | -31.82% |
| 2000 | 594.19 Thousand CAD | 18.84% |
| 1999 | 500 Thousand CAD | 25.0% |
| 1998 | 400 Thousand CAD | 0.0% |
| 1997 | 400 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 6.94 Million CAD | 17.28% |
| 2024 Q1 | 6.02 Million CAD | -8.42% |
| 2023 Q4 | 6.58 Million CAD | -6.78% |
| 2023 Q1 | 5.33 Million CAD | -13.87% |
| 2023 Q3 | 7.06 Million CAD | 8.7% |
| 2023 FY | 25.14 Million CAD | 10.0% |
| 2023 Q2 | 6.49 Million CAD | 21.78% |
| 2022 Q2 | 5.46 Million CAD | -2.27% |
| 2022 Q1 | 5.59 Million CAD | -3.97% |
| 2022 Q3 | 5.6 Million CAD | 2.66% |
| 2022 Q4 | 6.19 Million CAD | 10.41% |
| 2022 FY | 22.85 Million CAD | 0.97% |
| 2021 Q2 | 5.7 Million CAD | -2.61% |
| 2021 Q3 | 5.25 Million CAD | -7.82% |
| 2021 Q4 | 5.82 Million CAD | 10.74% |
| 2021 Q1 | 5.85 Million CAD | 33.1% |
| 2021 FY | 22.63 Million CAD | 29.92% |
| 2020 FY | 17.42 Million CAD | 4.67% |
| 2020 Q3 | 4.49 Million CAD | 20.54% |
| 2020 Q1 | 4.8 Million CAD | 10.06% |
| 2020 Q4 | 4.39 Million CAD | -2.1% |
| 2020 Q2 | 3.72 Million CAD | -22.36% |
| 2019 Q2 | 4.07 Million CAD | 15.64% |
| 2019 FY | 16.64 Million CAD | 0.43% |
| 2019 Q3 | 4.69 Million CAD | 15.27% |
| 2019 Q4 | 4.36 Million CAD | -7.03% |
| 2019 Q1 | 3.52 Million CAD | -21.79% |
| 2018 Q4 | 4.5 Million CAD | 9.67% |
| 2018 Q2 | 4.55 Million CAD | 33.26% |
| 2018 FY | 16.57 Million CAD | 3.75% |
| 2018 Q1 | 3.41 Million CAD | -24.26% |
| 2018 Q3 | 4.1 Million CAD | -9.84% |
| 2017 Q3 | 4.19 Million CAD | -1.06% |
| 2017 FY | 15.97 Million CAD | 13.08% |
| 2017 Q4 | 4.51 Million CAD | 7.56% |
| 2017 Q2 | 4.23 Million CAD | 39.78% |
| 2017 Q1 | 3.03 Million CAD | -21.59% |
| 2016 Q2 | 3.49 Million CAD | 14.42% |
| 2016 Q4 | 3.86 Million CAD | 4.3% |
| 2016 Q1 | 3.05 Million CAD | -1.32% |
| 2016 Q3 | 3.7 Million CAD | 6.06% |
| 2016 FY | 14.12 Million CAD | 16.65% |
| 2015 Q1 | 2.59 Million CAD | 8.52% |
| 2015 Q2 | 2.85 Million CAD | 9.92% |
| 2015 FY | 12.1 Million CAD | 27.06% |
| 2015 Q4 | 3.09 Million CAD | -13.06% |
| 2015 Q3 | 3.56 Million CAD | 24.74% |
| 2014 Q4 | 2.39 Million CAD | -14.21% |
| 2014 Q3 | 2.79 Million CAD | 14.41% |
| 2014 Q2 | 2.43 Million CAD | 27.77% |
| 2014 Q1 | 1.9 Million CAD | 12.65% |
| 2014 FY | 9.53 Million CAD | 54.84% |
| 2013 Q1 | 1.23 Million CAD | 14.57% |
| 2013 Q2 | 1.39 Million CAD | 13.46% |
| 2013 Q3 | 1.82 Million CAD | 30.65% |
| 2013 Q4 | 1.69 Million CAD | -7.33% |
| 2013 FY | 6.15 Million CAD | 54.5% |
| 2012 Q4 | 1.07 Million CAD | -12.16% |
| 2012 Q3 | 1.22 Million CAD | 26.86% |
| 2012 Q2 | 966.05 Thousand CAD | 34.94% |
| 2012 Q1 | 715.89 Thousand CAD | 25.52% |
| 2012 FY | 3.98 Million CAD | 80.5% |
| 2011 Q1 | 351.06 Thousand CAD | -0.02% |
| 2011 FY | 2.2 Million CAD | 78.53% |
| 2011 Q4 | 570.32 Thousand CAD | -26.4% |
| 2011 Q3 | 774.86 Thousand CAD | 51.65% |
| 2011 Q2 | 510.95 Thousand CAD | 45.55% |
| 2010 Q1 | 202.02 Thousand CAD | 173.03% |
| 2010 Q4 | 351.12 Thousand CAD | -24.17% |
| 2010 Q3 | 463.03 Thousand CAD | 110.33% |
| 2010 Q2 | 220.14 Thousand CAD | 8.97% |
| 2010 FY | 1.23 Million CAD | 86.35% |
| 2009 Q1 | 42.34 Thousand CAD | 119.96% |
| 2009 Q4 | 73.99 Thousand CAD | -80.15% |
| 2009 Q2 | 174.35 Thousand CAD | 311.72% |
| 2009 Q3 | 372.74 Thousand CAD | 113.78% |
| 2009 FY | 663.44 Thousand CAD | 2.44% |
| 2008 FY | 647.66 Thousand CAD | -14.97% |
| 2008 Q4 | 19.25 Thousand CAD | -93.55% |
| 2008 Q3 | 298.42 Thousand CAD | 90.61% |
| 2008 Q2 | 156.56 Thousand CAD | -9.72% |
| 2008 Q1 | 173.41 Thousand CAD | 336.29% |
| 2007 Q2 | 105.86 Thousand CAD | -43.76% |
| 2007 FY | 761.64 Thousand CAD | -25.79% |
| 2007 Q1 | 188.24 Thousand CAD | -40.72% |
| 2007 Q4 | 39.74 Thousand CAD | -90.71% |
| 2007 Q3 | 427.79 Thousand CAD | 304.1% |
| 2006 Q1 | 168.61 Thousand CAD | 288.98% |
| 2006 FY | 1.02 Million CAD | 165.81% |
| 2006 Q4 | 317.52 Thousand CAD | -29.11% |
| 2006 Q3 | 447.94 Thousand CAD | 342.36% |
| 2006 Q2 | 101.26 Thousand CAD | -39.95% |
| 2005 Q4 | 43.34 Thousand CAD | -75.03% |
| 2005 Q3 | 173.62 Thousand CAD | 47.04% |
| 2005 FY | 386.11 Thousand CAD | -12.16% |
| 2005 Q1 | 657.87 Thousand CAD | 1369.43% |
| 2005 Q2 | 118.08 Thousand CAD | -82.05% |
| 2004 Q4 | 44.77 Thousand CAD | -72.1% |
| 2004 Q1 | 121.21 Thousand CAD | 161.52% |
| 2004 Q2 | 113.12 Thousand CAD | -6.68% |
| 2004 FY | 439.56 Thousand CAD | -1.88% |
| 2004 Q3 | 160.45 Thousand CAD | 41.84% |
| 2003 Q1 | 25.04 Thousand CAD | 1998.94% |
| 2003 FY | 447.98 Thousand CAD | 22.73% |
| 2003 Q4 | 46.34 Thousand CAD | -79.22% |
| 2003 Q3 | 223.09 Thousand CAD | 45.34% |
| 2003 Q2 | 153.49 Thousand CAD | 512.82% |
| 2002 Q1 | 13.06 Thousand CAD | -79.45% |
| 2002 Q2 | 89.6 Thousand CAD | 585.77% |
| 2002 Q4 | -1319.00 CAD | -100.5% |
| 2002 FY | 365.02 Thousand CAD | -9.89% |
| 2002 Q3 | 263.66 Thousand CAD | 194.24% |
| 2001 Q3 | 262.85 Thousand CAD | 515.84% |
| 2001 Q1 | 35.98 Thousand CAD | -69.22% |
| 2001 FY | 405.09 Thousand CAD | -31.82% |
| 2001 Q4 | 63.58 Thousand CAD | -75.81% |
| 2001 Q2 | 42.68 Thousand CAD | 18.62% |
| 2000 Q4 | 116.9 Thousand CAD | -56.57% |
| 2000 Q3 | 269.16 Thousand CAD | 169.16% |
| 2000 Q2 | 100 Thousand CAD | 0.0% |
| 2000 Q1 | 100 Thousand CAD | 0.0% |
| 2000 FY | 594.19 Thousand CAD | 18.84% |
| 1999 Q3 | 400 Thousand CAD | 300.0% |
| 1999 Q4 | - CAD | -100.0% |
| 1999 Q1 | - CAD | 0.0% |
| 1999 FY | 500 Thousand CAD | 25.0% |
| 1999 Q2 | 100 Thousand CAD | 0.0% |
| 1998 Q1 | 200 Thousand CAD | 300.0% |
| 1998 Q4 | - CAD | -100.0% |
| 1998 FY | 400 Thousand CAD | 0.0% |
| 1998 Q3 | 200 Thousand CAD | 100.0% |
| 1998 Q2 | 100 Thousand CAD | -50.0% |
| 1997 Q4 | -100 Thousand CAD | -150.0% |
| 1997 Q3 | 200 Thousand CAD | 0.0% |
| 1997 FY | 400 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5499.00 CAD | -457121.404% |
| CanadaBis Capital Inc. | 11.78 Million CAD | -113.368% |
| Decibel Cannabis Company Inc. | 41.85 Million CAD | 39.935% |
| Delivra Health Brands Inc. | 6.39 Million CAD | -292.915% |
| Entourage Health Corp. | 3.7 Million CAD | -578.119% |
| Lifeist Wellness Inc. | 5.34 Million CAD | -370.458% |
| Cannara Biotech Inc. | 27.23 Million CAD | 7.668% |
| Medicure Inc. | 13.98 Million CAD | -79.731% |
| PharmaCielo Ltd. | -1.36 Million CAD | 1936.786% |
| Rubicon Organics Inc. | 13.14 Million CAD | -91.333% |
| Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 1150791.304% |